Skip to Content

Wednesday, August 5th, 2020

ADDE : AddLife publishes prospectus supplement

by April 6, 2016 General

(GlobeNewswire) – On the 30 March 2016, the Board of Directors of AddLife AB (publ) (AddLife)resolved on the terms and conditions of the share issue with preferential rightsfor existing shareholders in AddLife (the Issue). The terms and conditionswere published through a press release the same day. The decision regarding theterms and conditions of the Issue, as well as the acquisitions of V-Tech AB andEsthe-Tech AB and that AddLife signed an agreement to represent Leica Biosystemsin Sweden and Denmark, which have been published through press releases on 17March 2016 and 4 April 2016, respectively, required that a prospectus supplementwas prepared. The prospectus supplement has now been approved and registered bythe Swedish Financial Supervisory Authority. The prospectus supplement isavailable on the companys website,, as well as on Handelsbankenswebsite, Capital Markets acts as financial adviser and Advokatfirman Delphiacts as legal adviser in connection with the Issue.Stockholm, April 5, 2016AddLife AB (publ)For further information, please contact:Kristina Willgrd, CEO,, +46 70 510 12 23Martin Almgren, CFO,, +46 70 228 15 45IMPORTANT INFORMATIONThe information in this press release shall not constitute an offer to acquire,subscribe for or otherwise trade in shares or other securities in AddLife. Noaction has been taken and measures will not be taken to permit a public offeringin any jurisdictions other than Sweden. Invitation to the persons concerned tosubscribe for shares is only made through the prospectus which AddLife publishedon 15 March 2016.The information in this press release may not be released, published ordistributed, directly or indirectly, in or into the United States (including itsterritories and provinces, every state in the United States and the District ofColumbia), Canada, Australia, Japan, Hong Kong, New Zeeland, Switzerland,Singapore, South Africa or any other jurisdiction in which such action issubject to legal restrictions or would require other measures than thoserequired by Swedish law. Actions in violation of these restrictions mayconstitute a violation of applicable securities laws.No shares or other securities have or will be registered under the United StatesSecurities Act of 1933 or the securities legislation in any state or otherjurisdiction in the United States and may not be offered, subscribed, sold ortransferred, directly or indirectly, within the United States.AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, aboveall in the Nordic region. AddLife has about 425 employees in some 25subsidiaries that operate under their own brands. The Group has annual sales ofabout SEK 1.7 billion. Addlifes shares are listed on Nasdaq Stockholm.This information is disclosed in accordance with the Swedish Securities MarketsAct, the Swedish Financial Instruments Trading Act and/or the regulations ofNasdaq Stockholm. The information was provided for publication at 17:15 PM onApril 5 2016.(c) 2016 NNA LEBANON Provided by SyndiGate Media Inc. (, source Middle East & North African Newspapers